Final Procedure

The final procedure can now be designed based on the specific requirements of the experiment. The example used here is an experiment design from Table 10.1 above, a single-label immunocytochemistry experiment for Ag A in rat kidney tissue. In this chapter, the goal is to design a step-by-step procedure for each 1° antibody separately. 

Steps in a Single 1° Antibody Indirect Immunocytochemistry Experiment 

4% Paraformaldehyde in phosphate buffer fix 20% Sucrose in PBS Styrofoam and beaker for freezing tissue Aluminum foil 

Freezer -80°C for storing tissue Cryostat with several chucks Coated microscope slides Phosphate buffered saline (PBS) 

---

Ingots of EGS are evaluated for resistivity, crystal perfection, and mechanical and physical properties, such as she and mass. The iagots are sHced iato wafers usiag at least 10 machining and polishing procedures. These wafers are sHced sequentially from the iugot, and evaluated for the correct surface orientation, thickness, taper, and bow. As a final procedure, the wafers are chemically cleaned to remove surface contaminants prior to use. 

The individuals and firm most familiar with the technology should review the intermediate and final procedures to assure both safety and commercial interests are satisfied. In many batch operations the procedure(s) can be a substantial portion of the process technology package. The procedures represent both a major safety system as well as a propriety technology. The pre-startup review should assure both PHA related and other changes proposed to the procedures have been approved and implemented. 

The final procedure in the volume documents a convenient synthesis of the classical annulating reagent ETHYL 3-OXO-4-PENTENOATE (NAZAROV S REAGENT). 

During the method development, key method parameters are determined and used for subsequent validation steps to ensure that the validation data are generated under conditions equivalent to the final procedure (risk analysis).Aims of the method development are summarized in the list that follows. 

So, the final procedure can be described as follows we calculate an initial guess performing an ROHF calculation of the isolated and neutral cluster. Then, we add both the cluster charge and the background set of charges. If the value of the operator differs from 0.75 only at the third digit, we take this solution as acceptable and proceed to the MP2 calculation and population analysis. If the spin contamination is too large, we try to use different initial solutions until an acceptable solution is reached. 

Since our laboratory frequently uses HPLC for the final determination step, those assays were first chosen for automation. Each procedure was subdivided into discrete laboratory unit operations for final inclusion into the Zymate program. Each of these operations was also assigned to a module such as hand, master lab station, or blender. The sequence of operations and modules was then merged to arrive at a final procedure. This final procedure was then "taught" to the robot using a series of user-defined terms which could then be coupled into a program for that sample preparation. Since many of the laboratory operations are the same for many assays, an analyst needs to define only a limited number of terms to be intermixed into a variety of programs. 

Figure 11 summarizes the main steps of the treatment of the Saccha-romyces cerevisiae image (Fig. 2 a). There is usually one final procedure before quantitative characterization of each object or cell the purpose of the discrete labeling is to identify each individual and assign a number to it [52]. 

The final procedure we consider was proposed by Black (1958). He suggests that when an alternative beats all other alternatives in simple majority contests, it should be chosen if no such alternative exists, then the Borda rule should be used. Thus, we have... 

Before the TPS ether is cleaved with TBAF, secondary alcohol 7 has to be protected as methyl ether. TBAF is a reagent to cleave every silyl ether. Most other functional groups are not affected (see Chapter 2). In the next two steps the conversion of alcohol 33 into mesylate 34, which is a good leaving group, and then into iodide 35 in a Finkelstein type reaction occurs. Acetone is the solvent of choice, because Nal is better soluble in it than NaOMs and consequently reaction equilibrium is forced to the product side. Direct transformation from an alcohol to an iodide is possible with PPha and I2 in an Appel-like reaction, but in some cases this reaction fails. Final procedure is the generation of phosphonium salt 8. 

Four of the last five entries in this volume are convenient procedures to make functionalized molecules that are useful precursors to more complex structures METHYL 7-HYDROXYHEPT-S-YHOATE and 4-ttTH0XY-3-PENTEN-2-0NE, both of which, for example, are used in making prostaglandins 3-HYDROXY-l-CYCLOHEXENE-l-CARBOXALDEHYDE and (E)-2-(l-PR0PENYL)CYCL0BUTAN0NE. The final procedure describes a remarkably selective 4-CHLORINATION OF ELECTRON-RICH BEN2EN0ID COMPOUNDS by N-chlorodialkyl amines. 

Method Development Time - A new method based upon GC or HPLC can often be developed in less than one month - particularly for new chemicals belonging to a previously studied class or structural type. IA method developments, on the other hand, may require several months or several years as one synthesizes hapten derivatives, conjugates to protein, immunise. an animal to obtain antibodies, optimizes key assay parameters, and validates the final procedures. This becomes much less of a disadvantage if a stock of antibodies is available for the hapten of interest, in which case method development time for IA can be measured in weeks or a few months. 

SCHEME 7.14 The final procedure. After development and refinement, the dialkylation could be performed in one pot using a considerably smaller excess of cyclobutanone and a reaction time of only 8 h. 

---